Giant coronary artery aneurysms complicating Kawasaki disease in Mexican children

Cardiol Young. 2018 Mar;28(3):386-390. doi: 10.1017/S1047951117001470. Epub 2017 Aug 29.

Abstract

Background: One of the most important complications of Kawasaki disease is the development of giant coronary aneurysms. Risk factors for their development are still not clear.

Methods: A retrospective analysis was conducted at the National Institute of Paediatrics in Mexico City, Mexico. It included all patients with a diagnosis of acute Kawasaki disease between August, 1995 and August, 2015. Clinical and laboratory findings, as well as echocardiographic measurements, were recorded. Patients with giant coronary aneurysms (z-score⩾10) were compared with the rest of the patients. A value of p<0.05 was considered statistically significant. Odds ratios and their 95% confidence intervals were calculated to define risk factors.

Results: During the study period, 416 patients were diagnosed with Kawasaki disease. Of them, 34 developed giant coronary aneurysms during the acute stage of the disease. In the multivariate analysis, patients younger than 1 year, those with a higher duration of illness at the time of diagnosis, and those who received additional intravenous immunoglobulin showed a significantly higher frequency of giant coronary aneurysms.

Conclusions: One of the main factors associated with the development of giant coronary aneurysms was the delay in the diagnosis of Kawasaki disease. This finding highlights the importance of maintaining a high suspicion of the disease, which would enable an early diagnosis and prompt treatment and decrease the risk for developing giant coronary aneurysms.

Keywords: Kawasaki disease; giant coronary aneurysms; risk factors.

MeSH terms

  • Child, Preschool
  • Coronary Aneurysm / diagnostic imaging*
  • Coronary Aneurysm / drug therapy
  • Coronary Aneurysm / etiology
  • Coronary Vessels / pathology*
  • Echocardiography
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Infant
  • Infant, Newborn
  • Male
  • Mexico / epidemiology
  • Mucocutaneous Lymph Node Syndrome / complications*
  • Multivariate Analysis
  • Retrospective Studies
  • Risk Factors
  • Tertiary Care Centers
  • Time Factors

Substances

  • Immunoglobulins, Intravenous